SCHEMBL29979362

SCHEMBL29979362

CN(C)S(=O)(=O)c1ccc(S(=O)(=O)Nc2cc(Cl)ccc2N2CCCC(O)C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCOLN2 Q8IZK6 1/20 0.49
ALDH1A1 P00352 10/20 0.49
LMNA P02545 3/20 0.49
KDM4E B2RXH2 2/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 4/20 0.46
MEN1 O00255 2/20 0.46
GAA P10253 5/20 0.45
MAPT P10636 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
HTT P42858 4/20 0.44
USP2 O75604 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GPR55 Q9Y2T6 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23057110 0.89 ALDH1A1 (0.51) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL23057222 0.88 ALDH1A1 (0.49) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL29978639 0.83 ALDH1A1 (0.55) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL23057226 0.83 ALDH1A1 (0.55) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL29978597 0.81 ALDH1A1 (0.47) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL29978470 0.78 GAA (0.48) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL23057220 0.77 ALDH1A1 (0.53) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL29979661 0.76 GAA (0.51) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL29979103 0.76 MCOLN2 (0.46) MCOLN2ALDH1A1LMNAKDM4EHPGD
SCHEMBL23057021 0.74 MCOLN2 (0.53) MCOLN2ALDH1A1LMNAKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 MCOLN2 2/4885ALDH1A1 1368/4885LMNA 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.